Patterns of resistance to antituberculous drugs in Eastern Province, Saudi Arabia

Saudi Medical Journal

Volumn 20, Issue 12, 1999, Pages 927-930

  Al Jama, Abdulaziz A ^a   Borgio, Francis G ^b   Al Qatari, Khalid M ^b  

^a QATIF CENTRAL HOSPITAL   (Saudi Arabia)

^b Regional Laboratory and Blood Bank ^*  (Saudi Arabia)

Author keywords

Anti tuberculous drug resistance; Mycobacterium tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CULTURE MEDIUM; HUMAN; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SAUDI ARABIA; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0033385215     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Al-Amoud M. The history of tuberculosis. Saudi Medical Journal 1993; 575-580.
2. Nolan CM. Multidrug resistant tuberculosis in the USA: The end of the beginning. Tubercle and Lung Disease 1996; 77: 293-294.
3. Bener A. Prevalence of tuberculosis infection in Abha and Baha. Eur J Epidemiol 1990; 6(4): 376-381.
4. Miaat WA, Ali AS, Afif HA, Ghabrah TM. Epidemiology of Tuberculosis in Jeddah Region, Saudi Arabia. Saudi Medical Journal 1994; 15(2): 133-137.
5. Ministry of Health. Annual Health Report for 1416 & 1417.
6. Teklu B, Al-Wabel A. Tuberculin reaction in pulmonary tuberculosis in the Asir region of Saudi Arabia. Tubercle and Lung Disease 1993; 74: 20-22.
7. Al-Kassimi FA, Abdullah AK, Al-Hajjaj MS. Al-Orainey IO, Bamgboye EA, Chowdhary MNH. Nationwide community survey of tuberculosis epidemiology in Saudi Arabia. Tubercle and Lung Disease 1993; 74; 254-260.
8. Sudre P, Kochi GTDA. Tuberculosis: a global overview of the situation today. Bulletin of the World Health Organization 1992; 70(2): 149-159.
9. Tuberculosis notification update, WHO/TB/95. 182.
10. Ravigline MC, Snider DE Jr. Kochi A. Global epidemiology of Tuberculosis. JAMA 1995; 273 (3): 220-226.
11. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F. Global surveillance for anti-tuberculosis drug resistance 1994-1997. The NEJM 1998: 338 (23): 1641-1649.
12. Ai-Oramey IO. Resistance to standard anti-tuberculosis drugs in Saudi Arabia. Saudi Medical Journal 1986; 7(4): 363-368.
13. Ellis ME, Al-Hajjar S, Bokhari H, Quadn SMH. High proportion of multi drug resistant M. tuberculosis in Saudi Arabia. Scand J Infect Dis 1996; 28: 591-595.
14. Al-Orainey IO, Saeed ES, El-Kassimi FA, Al-Shareef N. Resistance to anti-tuberculosis drugs in Riyadh, Saudi Arabia. Tubercle 1989: 70; 207-220.
15. Schiott CR, Engback HC, Vergmann B, Al-Matez M, Kassim I. Incidence of drug resistance amongst isolates of Mycobacterium tuberculosis recovered in the Gizan area, Saudi Arabia. Saudi Medical Journal 1985; 6(4): 375-378.
16. Jarallah JS, Elias AK, Bukhan MS, Al-Shareef AHM, Al-Shammari SA. High rate of Rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia. Tubercle and Lung Disease 1992; 73: 113-115.
17. Zaman R. Tuberculosis in Saudi Arabia: Initial and secondary drug resistance among indigenous and non-indigenous populations. Tubercle 1991; 72: 51-55.
18. The Challenge of tuberculosis: statements on global control and prevention. Proceedings of the Lancet's conference on tuberculosis; 1995 Sept 14-15; Washington, USA. The Lancet 1995; 346: 809-810.
19. Anti-tuberculosis drug resistance; is it worth measuring? The WHOAUATLD working group on anti-tuberculosis drug resistance surveillance. Monaidi Arch Chest Dis 1996; 51 (4): 299-302.
20. Guidelines for surveillance of drug resistance in tuberculosis. WHOATB/94.178.